Critics Question World Health Organization's Stance on E-cigarettes

Regulations by 2FIRSTS.ai
Apr.10.2024
Critics Question World Health Organization's Stance on E-cigarettes
World Health Organization's statement on e-cigarette-induced seizures sparks controversy on social media, prompting fact-checking and debate.

According to a report by the Daily Mail, the World Health Organization recently made a statement on the social platform "X", claiming that e-cigarettes can cause seizures within a few hours, which has sparked criticism from various parties. The global health organization's statement on "X" was fact-checked by internet users, and the social platform later released a community statement.

 

Critics Question World Health Organization's Stance on E-cigarettes
Translate to English: WHO post | Image source: X

 

The announcement stated: "The basis of this post is research that has not been peer-reviewed and the evidence is uncertain. The basis of this statement is approximately 120 uncertain events that have occurred since 2019."

 

Dr. Charles Gardner, a developmental neurobiologist in Brooklyn, tweeted, "Please provide peer-reviewed evidence to support the claim that e-cigarettes 'typically' trigger seizures within 24 hours. If you cannot do this, please delete your tweet. Note: I have reviewed the literature and have not found any studies showing that e-cigarettes increase the risk of seizures.

 

In addition, some users have referred to the World Health Organization as clowns and liars, claiming that they are spreading propaganda. Steve Rolles, senior policy analyst at the Transform Drug Policy Foundation, also said, "I am convinced this is nonsense. Why is the World Health Organization's stance on e-cigarettes so peculiarly out of line?"

 

Critics Question World Health Organization's Stance on E-cigarettes
Supplementary statement of the WHO post | Image source: X

 

In a community announcement on "X," a link to an editorial on e-cigarettes and epilepsy was included. The editorial, published in the Journal of Adolescent Health, discusses a 2019 study analyzing 122 cases of seizure and other neurological symptoms in individuals who reported using e-cigarettes in the past 24 hours. Due to its potential to trigger seizures, researchers suggest that participants may be at risk for nicotine-induced epilepsy and symptoms.

 

However, the editorial pointed out that the details of the study "raise questions about causality, which must be considered when assessing the actual health risks of nicotine e-cigarettes for adolescents." It also noted, "A major question is why inhaling nicotine from e-cigarettes can trigger seizures, while inhaling nicotine from traditional tobacco does not.

 

The authors point out that a person would need to inhale a large dose of nicotine to trigger a seizure, but e-cigarette devices contain much lower levels of nicotine compared to traditional cigarettes. Additionally, the toxic effects of high doses of nicotine are expected to appear within minutes of inhalation and dissipate within a few hours. The authors state, "Seizures do not seem likely to occur if there are no other systemic toxic effects present.

 

In the United States, the use of e-cigarettes has reached record levels, with over 17 million adults and 2 million children addicted to these devices. An editorial pointed out a flaw in a 2019 study, stating that the analysis of reported seizures was based on self-reporting and not always clear. Descriptions varied, with some individuals reporting severe seizures while others detailed tremors or seizure-like activity. In most cases, these events were not evaluated by medical professionals. The editorial's author noted that nicotine could potentially cause anxiety attacks and unconscious muscle contractions, leading some individuals to misinterpret these symptoms as seizures, even though they are not.

 

Despite traditional cigarette smoking rates decreasing each year, the number of people using e-cigarettes is continuously increasing, especially among middle and high school students. An analysis from the Centers for Disease Control and Prevention (CDC) in 2023 found that 2.1 million children, or nearly 8% of the student population, are using these devices, with 47% of children who have tried e-cigarettes still currently using them.

 

E-cigarettes typically come in attractive flavors such as cotton candy and caramel custard, and their packaging designs appeal to younger users. Data shows that approximately 90% of young people report having used products with fruit or candy flavors.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

IKE Tech Launches IKE 2.0 Compliance Platform for Nicotine Products
IKE Tech Launches IKE 2.0 Compliance Platform for Nicotine Products
IKE Tech launched IKE 2.0 on September 28, initially targeting nicotine products with a platform that combines user identity verification, product authentication, configurable policy controls and data analytics. Products can be authenticated through direct device integration or NFC smart tags. IKE Tech was formed with participation from Ispire's Aspire North America, Berify and Chemular, with Ispire currently holding a 40% interest. Its age-verification component PMTA was accepted by the FDA in 2025 and remains under review. The company did not disclose customer names, commercial deployment volumes, pricing or revenue tied to IKE 2.0.
News
Sep.29 by 2Firsts Perspectives
JTI Proposes 25-Cent Irish Cigarette Tax Increase, Says It Could Raise €45 Million
JTI Proposes 25-Cent Irish Cigarette Tax Increase, Says It Could Raise €45 Million
Japan Tobacco International's Irish business has proposed a €0.25 tax increase on a pack of 20 cigarettes in its pre-Budget 2027 submission, below the €0.50-or-more increases typically imposed in recent Irish budgets. JTI says the proposal could generate around €45 million in additional Exchequer revenue while limiting further movement toward illicit and non-Irish-tax-paid tobacco. Revenue's existing estimate for a comparable €0.25 increase, including pro-rata rises on other tobacco products, is about €18 million for a full year.
JTI
Sep.18 by 2Firsts Perspectives
Product | PMI Launches ZYN Melts in UK, Extending ZYN Beyond Nicotine Pouches Into Dissolvable Tablets
Product | PMI Launches ZYN Melts in UK, Extending ZYN Beyond Nicotine Pouches Into Dissolvable Tablets
Philip Morris International (PMI) has launched ZYN Melts in the UK, introducing a fully dissolvable oral nicotine tablet format alongside the brand's existing nicotine pouches. The range includes Cool Mint and Peppermint, each offered at 1mg and 2mg of nicotine per tablet, creating four SKUs. Each can contains 20 tablets and is priced at £6.50 in the UK. Unlike ZYN nicotine pouches, Melts are placed between the upper lip and gum and dissolve completely during use.
News
Sep.29 by 2Firsts Perspectives
China Tobacco Plans CNY 60 Billion Investment in ICBC, Agricultural Bank as Strategic Ties Extend Beyond Equity
China Tobacco Plans CNY 60 Billion Investment in ICBC, Agricultural Bank as Strategic Ties Extend Beyond Equity
China National Tobacco Corporation and several subsidiaries plan to invest a combined CNY 60 billion ($8.7 billion) in share placements by Industrial and Commercial Bank of China and Agricultural Bank of China as strategic investors. The agreements extend beyond equity investment to corporate governance, banking services and supply-chain finance. The filings also disclose 2025 data on China Tobacco’s tax and profit contributions and industry scale.
Sep.07
JTI Invests ₱2.1 Billion to Upgrade Batangas Manufacturing Hub, Adds First Southeast Asia DIET Facility
JTI Invests ₱2.1 Billion to Upgrade Batangas Manufacturing Hub, Adds First Southeast Asia DIET Facility
JTI Asia Manufacturing Corp. has invested ₱2.1 billion, or about $37 million, in its manufacturing site in Malvar, Batangas, Philippines, to expand tobacco-processing capabilities. About ₱1.9 billion is allocated to JTI's first Dry Ice Expanded Tobacco, or DIET, facility in Southeast Asia, while more than ₱177 million has been spent on expanding its Controlled Atmosphere treatment facility. The Batangas plant supplies the Philippine market and exports to 22 overseas markets, making it one of JTI's key manufacturing hubs in Asia.
Sep.24
2Firsts On-Site | PMI Brings IQOS, ZYN, VEEV and Marlboro Together at Its “Boulevard” at InterTabac 2026
2Firsts On-Site | PMI Brings IQOS, ZYN, VEEV and Marlboro Together at Its “Boulevard” at InterTabac 2026
At InterTabac 2026 in Dortmund, PMI is presenting multiple brands and products along “The PMI Boulevard,” including IQOS, ZYN, VEEV and Marlboro. On-site images captured by 2Firsts show dedicated spaces including the IQOS Boutique, ZYN Café, PMI Gallery and Marlboro Office
Market
Sep.16 by 2Firsts Perspectives